These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 30564897

  • 1. Oxime K203: a drug candidate for the treatment of tabun intoxication.
    Gorecki L, Soukup O, Kucera T, Malinak D, Jun D, Kuca K, Musilek K, Korabecny J.
    Arch Toxicol; 2019 Mar; 93(3):673-691. PubMed ID: 30564897
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Musilek K, Kuca K, Bajgar J, Jung YS.
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The Evaluation of the Reactivating and Neuroprotective Efficacy of Two Newly Prepared Bispyridinium Oximes (K305, K307) in Tabun-Poisoned Rats-A Comparison with Trimedoxime and the Oxime K203.
    Kassa J, Misik J, Hatlapatkova J, Zdarova Karasova J, Sepsova V, Caisberger F, Pejchal J.
    Molecules; 2017 Jul 11; 22(7):. PubMed ID: 28696367
    [Abstract] [Full Text] [Related]

  • 8. A comparison of the therapeutic and reactivating efficacy of newly developed oximes (K117, K127) and currently available oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J, Karasova J, Musilek K, Kuca K, Jung YS.
    Drug Chem Toxicol; 2008 Jul 11; 31(3):371-81. PubMed ID: 18622871
    [Abstract] [Full Text] [Related]

  • 9. The evaluation of the reactivating and therapeutic efficacy of two novel oximes (K361 and K378) in comparison with the oxime K203 and trimedoxime in tabun-poisoned rats and mice.
    Kassa J, Sepsova V, Tumova M, Musilek K, Horova A.
    Toxicol Mech Methods; 2014 Mar 11; 24(3):173-8. PubMed ID: 24295433
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase.
    Kuca K, Musilek K, Jun D, Zdarova-Karasova J, Nepovimova E, Soukup O, Hrabinova M, Mikler J, Franca TCC, Da Cunha EFF, De Castro AA, Valis M, Ramalho TC.
    BMC Pharmacol Toxicol; 2018 Feb 21; 19(1):8. PubMed ID: 29467029
    [Abstract] [Full Text] [Related]

  • 12. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
    Lo R, Ganguly B.
    Mol Biosyst; 2014 Jul 29; 10(9):2368-83. PubMed ID: 24964273
    [Abstract] [Full Text] [Related]

  • 13. The influence of combinations of oximes on the reactivating and therapeutic efficacy of antidotal treatment of tabun poisoning in rats and mice.
    Kassa J, Karasova JZ, Pavlikova R, Misik J, Caisberger F, Bajgar J.
    J Appl Toxicol; 2010 Mar 29; 30(2):120-4. PubMed ID: 19746406
    [Abstract] [Full Text] [Related]

  • 14. A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
    Kassa J, Jun D, Kuca K.
    J Enzyme Inhib Med Chem; 2007 Jun 29; 22(3):297-300. PubMed ID: 17674811
    [Abstract] [Full Text] [Related]

  • 15. A comparison of the potency of newly developed oximes (K074, K075) and currently available oximes (obidoxime, trimedoxime, HI-6) to counteract acute toxic effects of tabun and cyclosarin in mice.
    Kassa J, Humlicek V.
    Drug Chem Toxicol; 2008 Jun 29; 31(1):127-35. PubMed ID: 18161512
    [Abstract] [Full Text] [Related]

  • 16. A comparison of neuroprotective efficacy of two novel reactivators of acetylcholinesterase called K920 and K923 with the oxime K203 and trimedoxime in tabun-poisoned rats.
    Kassa J, Misik J, Hatlapatkova J, Zdarova Karasova J.
    Toxicol Mech Methods; 2017 Mar 29; 27(3):236-243. PubMed ID: 28043192
    [Abstract] [Full Text] [Related]

  • 17. Revealing the importance of linkers in K-series oxime reactivators for tabun-inhibited AChE using quantum chemical, docking and SMD studies.
    Ghosh S, Chandar NB, Jana K, Ganguly B.
    J Comput Aided Mol Des; 2017 Aug 29; 31(8):729-742. PubMed ID: 28646405
    [Abstract] [Full Text] [Related]

  • 18. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K, Cabal J, Kassa J, Jun D, Hrabinova M.
    J Toxicol Environ Health A; 2006 Aug 29; 69(15):1431-40. PubMed ID: 16766478
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the Influence of Three Newly Developed Bispyridinium Anti-nicotinic Compounds (MB408, MB442, MB444) on the Efficacy of Antidotal Treatment of Nerve Agent Poisoning in Mice.
    Kassa J, Timperley CM, Bird M, Williams RL, Green AC, Tattersall JEH.
    Basic Clin Pharmacol Toxicol; 2018 Apr 29; 122(4):429-435. PubMed ID: 29117635
    [Abstract] [Full Text] [Related]

  • 20. A comparison of neuroprotective efficacy of the oxime K203 and its fluorinated analogue (KR-22836) with obidoxime in Tabun-poisoned rats.
    Kassa J, Karasova JZ, Tesarova S, Musilek K, Kuca K, Jung YS.
    Basic Clin Pharmacol Toxicol; 2010 Nov 29; 107(5):861-7. PubMed ID: 22545968
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.